Lyme/MSIDS has been in a never-ending time warp. For patients who are educated on the horrific backstory, they were completely aware of COVID madness before most of the public. The same tricks have been used. The same fraud, corruption, and lies Lymeland has been dealing with for over 40 years are now finally being seen and felt by the general pubic.
(84%) had no findings of active Lyme disease??
JAN 17, 2023 —
Here is how the industrial medical complex promotes the disinformation to perpetuate an existing dogma. You won’t find any of my references in Dr. Auwaerter’s publication. Why is that???
Inquiry to Dr. Paul G. Auwaerter
———- Original Message ———-
From: CARL TUTTLE <firstname.lastname@example.org>
To: “email@example.com” <firstname.lastname@example.org>
Cc: “Takaakiemail@example.com” <Takaakifirstname.lastname@example.org>, “email@example.com” <firstname.lastname@example.org>, “email@example.com” <firstname.lastname@example.org>, “email@example.com” <firstname.lastname@example.org>, “email@example.com” <firstname.lastname@example.org>
Date: 01/16/2023 2:57 PM
Subject: Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease
The American Journal of Medicine April 2022
Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease (Apr 2022)
Takaaki Kobayashi MD, Yvonne Higgins MAS, MS Michael T.Melia MD Paul G.Auwaerter MD
“Of 1261 referred patients, 1061 (84%) had no findings of active Lyme disease…”
Paul G. Auwaerter MD
Division of Infectious Diseases
Department of Medicine
Johns Hopkins University School of Medicine
Dear Dr. Auwaerter,
I read your abstract with great interest but I must ask the question; how did you determine that 84% had no findings of active Lyme disease? Were these results obtained through serology?
Seronegative Lyme disease has been reported for years. I have attached a list of publications for your review:
Seronegativity in Lyme borreliosis and Other Spirochetal Infections
(16 September 2003)
European Neurology 1995
Seronegative Chronic Relapsing Neuroborreliosis
Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d
We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
Patients who were featured in the 5min extended trailer for the documentary “Under our Skin” claim the following:
– Misdiagnosed with Chronic Fatigue Syndrome, Lupus, MS, Fibromyalgia, ALS
“Under our Skin” extended trailer (5min)
Western blot reporting criteria was manipulated in 1995 to facilitate vaccine development. (Dearborn Conference)
That manipulation led to a reduction in diagnostic success rate to 31% as reported by Dr. Paul Fawcett during the 1995 Rheumatology Symposia:
1995 Rheumatology Symposia Abstract# 1254 Dr. Paul Fawcett et al.
View Dr. Paul fawcett’s Abstract 1254 here
Dr. Fawcett has been the head of the research and clinical immunology laboratories since 1986. In addition, he serves as Chair of the IACUC and is a member of the IRB.
Even more significant is Dennis Parenti’s 1998 vaccine presentation (Lyme.org at 1 hr 9 minutes). Dr. Parenti, medical director of the vaccine trial – the largest Lyme trial in history, discusses the research findings of seronegative Lyme. At 36% it is a common presentation. This proves that a negative western blot is meaningless. Since their patients were culture positive and/or DNA positive for Borrelia infection and western blot negative.
View Dennis Parenti’s 1998 vaccine presentation slide here
As you should know Dr. Auwaerter, serology cannot be used to gauge treatment failure or success so I ask the question again: how did you determine that 84% had no findings of active Lyme disease?
A response to this inquiry is requested.
Cc: Joseph Alpert, MD, MACP Editor-in-Chief, The American Journal of Medicine
Mary Woolley President and CEO of Research!America